Schistosoma japonicum sja-let-7 Inhibits the Growth of Hepatocellular Carcinoma Cells via Cross-Species Regulation of Col1α2

文献类型: 外文期刊

第一作者: Zhong, Haoran

作者: Zhong, Haoran;Dong, Bowen;Zhu, Danlin;Fu, Zhiqiang;Liu, Jinming;Jin, Yamei;Guan, Guiquan

作者机构:

关键词: liver fibrosis; hepatocellular carcinoma; schistosome; sja-let-7; Col1 alpha 2

期刊名称:GENES ( 影响因子:2.8; 五年影响因子:3.2 )

ISSN:

年卷期: 2024 年 15 卷 9 期

页码:

收录情况: SCI

摘要: Liver fibrosis, a critical precursor to hepatocellular carcinoma (HCC), results from chronic liver injury and significantly contributes to HCC progression. Schistosomiasis, a neglected tropical disease, is known to cause liver fibrosis; however, this process can be modulated by schistosome-derived miRNAs. Previous studies from our laboratory have demonstrated that Schistosoma japonicum extracellular vesicles (EVs) deliver sja-let-7 to hepatic stellate cells, leading to the inhibition of Col1 alpha 2 expression and alleviation of liver fibrosis. Given the well-documented antifibrotic and antiproliferative properties of the let-7 miRNA family, this study aims to preliminarily investigate the effects of the sja-let-7/Col1 alpha 2 axis on BALB/c mice and HCC cell line SNU387, providing a basis for the potential application of parasite-derived molecules in HCC therapy. In the present study, schistosome-induced fibrosis datasets were analyzed to identify the role of Col1 alpha 2 in extracellular matrix organization. Pan-cancer analysis revealed that Col1 alpha 2 is upregulated in various cancers, including HCC, with significant associations with immune cell infiltration and clinical parameters, highlighting its diagnostic importance. Functional assays demonstrated that transfection with sja-let-7 mimics significantly reduced Col1 alpha 2 expression, inhibited HCC cell proliferation, migration, and colony formation. These findings suggest that sja-let-7, by targeting Col1 alpha 2, has the potential to serve as a therapeutic agent in HCC treatment. This study indicates the pivotal role of Col1 alpha 2 in liver fibrosis and HCC, and the promising therapeutic application of helminth-derived miRNAs.

分类号:

  • 相关文献
作者其他论文 更多>>